Skip to main content

Table 2 Factors associated with exposure to the main intervention components: Assessment of lifestyle (A1), and prescription of lifestyle change (A4)

From: Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy—the PVS-PREDIAPS strategy—to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial

Variables Adjusted hazard ratio (95% CI)
Assessed (A1) Prescribed (A4)
Age in years ≥ 75 1.00 1.00
  30-54 3.14 (2.21-4.47) 3.33 (1.97-5.64)
  55-64 4.64 (3.40-6.33) 5.76 (3.63-9.12)
  65-75 3.96 (2.91-5.40) 4.51 (2.85-7.14)
Sex Female 1.00 1.00
Male 0.90 (0.75-1.08) 0.85 (0.66-1.09)
Chol > 240 No 1.00 1.00
Yes 0.71 (0.55-0.92) 0.69 (0.45-0.99)
DBP > 90 No 1.00 1.00
Yes 0.69 (0.52-0.92) 0.77 (0.53-1.13)
BMI ≥ 30 No 1.00 1.00
Yes 1.28 (1.07-1.54) 1.35 (1.05-1.74)
Group Global 1.00 1.00
0-8 months Sequential 0.98 (0.79-1.20) 1.02 (0.76-1.36)
9-12 months Sequential 2.61 (1.77-3.83) 2.33 (1.38-3.94)
  1. Note: BMI, body mass index in kg/m2; Chol, cholesterol level in mg/dL; DBP, diastolic blood pressure in mmHg